GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » Scaled Net Operating Assets

Acrobiosystems Co (SZSE:301080) Scaled Net Operating Assets : 0.27 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Acrobiosystems Co's operating assets for the quarter that ended in Mar. 2024 was ¥857.9 Mil. Acrobiosystems Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥108.0 Mil. Acrobiosystems Co's Total Assets for the quarter that ended in Dec. 2023 was ¥2,813.5 Mil. Therefore, Acrobiosystems Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.27.


Acrobiosystems Co Scaled Net Operating Assets Historical Data

The historical data trend for Acrobiosystems Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co Scaled Net Operating Assets Chart

Acrobiosystems Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.64 1.00 0.90 0.22 0.24

Acrobiosystems Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.23 0.24 0.24 0.27

Competitive Comparison of Acrobiosystems Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Acrobiosystems Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acrobiosystems Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Acrobiosystems Co's Scaled Net Operating Assets falls into.



Acrobiosystems Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Acrobiosystems Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(826.97-160.613)/2735.96
=0.24

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2813.498 - 1986.528
=826.97

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=225.225 - 38.502 - 26.11
=160.613

Acrobiosystems Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(857.937-108.038)/2813.498
=0.27

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2812.122 - 1954.185
=857.937

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=191.174 - 36.846 - 46.29
=108.038

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acrobiosystems Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrobiosystems Co (SZSE:301080) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co (SZSE:301080) Headlines

No Headlines